Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities
Net income	$ 5,089,000	$ 8,416,000
Adjustments to reconcile net income to net cash from operating activities
Depreciation and amortization	1,967,000	1,086,000
Accretion of acquired loans	(512,000)	0
Provision for loan losses	(2,600,000)	(3,000,000)
Stock-based compensation expense	351,000	236,000
Proceeds from sales of mortgage loans held for sale	16,958,000	29,298,000
Origination of mortgage loans held for sale	(16,525,000)	(28,383,000)
Net gain from sales of mortgage loans held for sale	(383,000)	(395,000)
Net gain from sale and valuation write-down of foreclosed assets	(605,000)	(895,000)
Earnings on bank owned life insurance	(581,000)	(688,000)
Net change in:
Accrued interest receivable	312,000	214,000
Other assets	(1,678,000)	11,930,000
Accrued interest and other liabilities	(5,844,000)	(1,368,000)
Net cash from (for) operating activities	(4,051,000)	16,451,000
Cash flows from investing activities
Cash received in merger	91,806,000	0
Loan originations and payments, net	(75,655,000)	(20,433,000)
Purchases of securities available for sale	(11,679,000)	(28,973,000)
Proceeds from maturities, calls and repayments of securities available for sale	22,800,000	28,538,000
Proceeds from sales of securities available for sale	0	3,905,000
Proceeds from sales of foreclosed assets	1,940,000	5,659,000
Purchases of premises and equipment	(874,000)	(134,000)
Net cash from (for) investing activities	28,338,000	(11,438,000)
Cash flows from financing activities
Net decrease in time deposits	(15,516,000)	(51,608,000)
Net decrease in all other deposits	(29,743,000)	(22,281,000)
Net increase (decrease) in securities sold under agreements to repurchase	319,000	(7,437,000)
Net increase in other borrowed money	12,728,000	49,000
Proceeds from stock option exercises	75,000	0
Employee stock purchase plan	0	19,000
Dividend reinvestment plan	0	33,000
Stock grants to directors for retainer fee	155,000	0
Payment of cash dividends to common shareholders	(20,417,000)	(1,814,000)
Net cash for financing activities	(52,399,000)	(83,039,000)
Net change in cash and cash equivalents	(28,112,000)	(78,026,000)
Cash and cash equivalents at beginning of period	146,965,000	136,003,000
Cash and cash equivalents at end of period	118,853,000	57,977,000
Cash paid during the period for:
Interest	5,336,000	6,068,000
Federal income tax	1,400,000	0
Noncash financing and investing activities:
Transfers from loans to foreclosed assets	$ 175,000	$ 1,710,000